Search research articles
Contact Us
Filters
Showing results (31-40 of 73) with videos related to
Page
of 8
Sort By:
International Journal of Molecular Sciences
|
October 29, 2025
Clinical Impact of LAG3 Single-Nucleotide Polymorphism in DLBCL Treated with CAR-T Cell Therapy
Katja Seipel, Sophia Maria Spahr, Inna Shaforostova, et al.
Current Issues in Molecular Biology
|
August 28, 2024
Rising Prevalence of Low-Frequency <i>PPM1D</i> Gene Mutations after Second HDCT in Multiple Myeloma
Katja Seipel, Nuria Z Veglio, Henning Nilius, et al.
Cancers
|
May 28, 2022
Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy
Vera Rentsch, Katja Seipel, Yara Banz, et al.
Current Issues in Molecular Biology
|
August 27, 2025
Serum Immunoglobulin Changes in Multiple Myeloma Patients Treated with CAR T-Cell Therapy
Alexa Burger, Ulrike Bacher, Michele Hoffmann, et al.
Journal of Clinical Medicine
|
February 27, 2026
AL Amyloidosis Patients Continue to Benefit from HDCT/ASCT Consolidation in the Daratumumab Era
Julia Bee, Inna Shaforostova, Michèle Hoffmann, et al.
Cancers
|
March 28, 2026
Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab
Maeva Ullmann, Katja Seipel, Henning Nilius, et al.
Leukemia & Lymphoma
|
October 14, 2016
Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy
Jasmin Stettler, Urban Novak, Gabriela M Baerlocher, et al.
Current Oncology (Toronto, Ont.)
|
December 22, 2023
Low-Frequency <i>PPM1D</i> Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma
Katja Seipel, Michèle Frey, Henning Nilius, et al.
Current Issues in Molecular Biology
|
January 30, 2026
Elevated Allele Frequency and Male-Predominance of a Common <i>LAG3</i> Germline Variant in Multiple Myeloma
Katja Seipel, Alina Mena, Pinar Horum, et al.
Biomedicines
|
June 26, 2026
Influence of <i>PPM1D</i> Mutations on Response and Survival Outcomes Following Bispecific Antibody Therapy in Relapsed and Refractory Multiple Myeloma Patients
Elena Fiori, Martina Bertschinger, Ulrike Bacher, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 73) with videos related to
Sort By:
Page
of 8
International Journal of Molecular Sciences
|
October 29, 2025
Clinical Impact of LAG3 Single-Nucleotide Polymorphism in DLBCL Treated with CAR-T Cell Therapy
Katja Seipel, Sophia Maria Spahr, Inna Shaforostova, et al.
Current Issues in Molecular Biology
|
August 28, 2024
Rising Prevalence of Low-Frequency <i>PPM1D</i> Gene Mutations after Second HDCT in Multiple Myeloma
Katja Seipel, Nuria Z Veglio, Henning Nilius, et al.
Cancers
|
May 28, 2022
Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy
Vera Rentsch, Katja Seipel, Yara Banz, et al.
Current Issues in Molecular Biology
|
August 27, 2025
Serum Immunoglobulin Changes in Multiple Myeloma Patients Treated with CAR T-Cell Therapy
Alexa Burger, Ulrike Bacher, Michele Hoffmann, et al.
Journal of Clinical Medicine
|
February 27, 2026
AL Amyloidosis Patients Continue to Benefit from HDCT/ASCT Consolidation in the Daratumumab Era
Julia Bee, Inna Shaforostova, Michèle Hoffmann, et al.
Cancers
|
March 28, 2026
Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab
Maeva Ullmann, Katja Seipel, Henning Nilius, et al.
Leukemia & Lymphoma
|
October 14, 2016
Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy
Jasmin Stettler, Urban Novak, Gabriela M Baerlocher, et al.
Current Oncology (Toronto, Ont.)
|
December 22, 2023
Low-Frequency <i>PPM1D</i> Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma
Katja Seipel, Michèle Frey, Henning Nilius, et al.
Current Issues in Molecular Biology
|
January 30, 2026
Elevated Allele Frequency and Male-Predominance of a Common <i>LAG3</i> Germline Variant in Multiple Myeloma
Katja Seipel, Alina Mena, Pinar Horum, et al.
Biomedicines
|
June 26, 2026
Influence of <i>PPM1D</i> Mutations on Response and Survival Outcomes Following Bispecific Antibody Therapy in Relapsed and Refractory Multiple Myeloma Patients
Elena Fiori, Martina Bertschinger, Ulrike Bacher, et al.
Page
of 8